Pharmacokinetic-pharmacodynamic relationship
- PMID: 2080844
Pharmacokinetic-pharmacodynamic relationship
Abstract
The dose-effect relationship can be determined by linking pharmacokinetic drug behavior with information on pharmacodynamic activity. This requires that the quantifiable concentrations of drug (or metabolites) in the plasma (systemic circulation) are related to the concentration at the site of action. Using the pharmacokinetic parameters and a pharmacokinetic-pharmacodynamic model, it is possible to predict the pharmacodynamic response to certain drugs; this provides useful information for understanding drug action and to determine dosage regimen.
Similar articles
-
Pharmacokinetic parameters: which are necessary to define a drug substance?Eur J Respir Dis Suppl. 1984;134:45-61. Eur J Respir Dis Suppl. 1984. PMID: 6586486
-
Pharmacokinetic and pharmacodynamic modeling in vivo.Crit Rev Bioeng. 1981;5(4):273-322. Crit Rev Bioeng. 1981. PMID: 7023829 Review.
-
Basic principles of pharmacologic action.Nurs Clin North Am. 1991 Jun;26(2):245-62. Nurs Clin North Am. 1991. PMID: 2047284 Review.
-
Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.Int J Clin Pharmacol Ther. 1998 Mar;36(3):168-75. Int J Clin Pharmacol Ther. 1998. PMID: 9562234
-
Primer on clinical pharmacokinetics.Am J Hosp Pharm. 1983 Oct;40(10):1637-41. Am J Hosp Pharm. 1983. PMID: 6638025
Cited by
-
Nanotechnology Based Approaches in Phage Therapy: Overcoming the Pharmacological Barriers.Front Pharmacol. 2021 Oct 5;12:699054. doi: 10.3389/fphar.2021.699054. eCollection 2021. Front Pharmacol. 2021. PMID: 34675801 Free PMC article. Review.
-
Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis.J Pers Med. 2021 Jun 29;11(7):617. doi: 10.3390/jpm11070617. J Pers Med. 2021. PMID: 34210056 Free PMC article. Review.
-
Development, biological evaluation, and molecular modelling of some benzene-sulfonamide derivatives as protein tyrosine phosphatase-1B inhibitors for managing diabetes mellitus and associated metabolic disorders.RSC Med Chem. 2024 Oct 23;16(1):247-73. doi: 10.1039/d4md00594e. Online ahead of print. RSC Med Chem. 2024. PMID: 39464651 Free PMC article.
-
Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach.Pharm Res. 2016 Oct;33(10):2565-79. doi: 10.1007/s11095-016-1982-5. Epub 2016 Jul 28. Pharm Res. 2016. PMID: 27469324
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical